Follow
Karl-Johan Malmberg
Karl-Johan Malmberg
Professor of Immunology at University of Oslo
No verified email
Title
Cited by
Cited by
Year
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
T Sekine, A Perez-Potti, O Rivera-Ballesteros, K Strålin, JB Gorin, ...
Cell 183 (1), 158-168. e14, 2020
19062020
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
NK Björkström, P Riese, F Heuts, S Andersson, C Fauriat, MA Ivarsson, ...
Blood, The Journal of the American Society of Hematology 116 (19), 3853-3864, 2010
7882010
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function
H Schlums, F Cichocki, B Tesi, J Theorell, V Beziat, TD Holmes, H Han, ...
Immunity 42 (3), 443-456, 2015
7272015
Prospects for the use of NK cells in immunotherapy of human cancer
HG Ljunggren, KJ Malmberg
Nature Reviews Immunology 7 (5), 329-339, 2007
6862007
Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus
NK Björkström, T Lindgren, M Stoltz, C Fauriat, M Braun, M Evander, ...
Journal of Experimental Medicine 208 (1), 13-21, 2011
5342011
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
V Béziat, LL Liu, JA Malmberg, MA Ivarsson, E Sohlberg, AT Björklund, ...
Blood, The Journal of the American Society of Hematology 121 (14), 2678-2688, 2013
5332013
Natural killer cell immunotypes related to COVID-19 disease severity
C Maucourant, I Filipovic, A Ponzetta, S Aleman, M Cornillet, L Hertwig, ...
Science immunology 5 (50), eabd6832, 2020
3952020
Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
C Fauriat, MA Ivarsson, HG Ljunggren, KJ Malmberg, J Michaëlsson
Blood, The Journal of the American Society of Hematology 115 (6), 1166-1174, 2010
3422010
CMV drives clonal expansion of NKG2C+ NK cells expressing self‐specific KIRs in chronic hepatitis patients
V Béziat, O Dalgard, T Asselah, P Halfon, P Bedossa, A Boudifa, ...
European journal of immunology 42 (2), 447-457, 2012
3232012
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
JA Wagner, M Rosario, R Romee, MM Berrien-Elliott, SE Schneider, ...
The Journal of clinical investigation 127 (11), 4042-4058, 2017
3162017
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
M Carlsten, NK Björkström, H Norell, Y Bryceson, T van Hall, ...
Cancer research 67 (3), 1317-1325, 2007
3092007
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells
M Carlsten, H Norell, YT Bryceson, I Poschke, K Schedvins, ...
The Journal of Immunology 183 (8), 4921-4930, 2009
2952009
Natural killer cell-mediated immunosurveillance of human cancer
KJ Malmberg, M Carlsten, A Björklund, E Sohlberg, YT Bryceson, ...
Seminars in immunology 31, 20-29, 2017
2622017
IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism
KJ Malmberg, V Levitsky, H Norell, CT De Matos, M Carlsten, K Schedvins, ...
The Journal of clinical investigation 110 (10), 1515-1523, 2002
2542002
Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas
Y Rongcun, F Salazar-Onfray, J Charo, KJ Malmberg, K Evrin, H Maes, ...
The Journal of Immunology 163 (2), 1037-1044, 1999
2461999
Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease
JM Munneke, AT Björklund, JM Mjösberg, K Garming-Legert, JH Bernink, ...
Blood, The Journal of the American Society of Hematology 124 (5), 812-821, 2014
2362014
Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?
KJ Malmberg
Cancer Immunology, Immunotherapy 53, 879-892, 2004
2312004
Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans
LL Liu, J Landskron, EH Ask, M Enqvist, E Sohlberg, JA Traherne, ...
Cell reports 15 (5), 1088-1099, 2016
2282016
Role for early-differentiated natural killer cells in infectious mononucleosis
T Azzi, A Lünemann, A Murer, S Ueda, V Béziat, KJ Malmberg, G Staubli, ...
Blood, The Journal of the American Society of Hematology 124 (16), 2533-2543, 2014
2212014
Metabolic reprograming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity
H Zhu, RH Blum, D Bernareggi, EH Ask, Z Wu, HJ Hoel, Z Meng, C Wu, ...
Cell Stem Cell 27 (2), 224-237. e6, 2020
2022020
The system can't perform the operation now. Try again later.
Articles 1–20